← Latest news 
India obesity drug market set to surge as oral GLP1 pills replace injections for millions
Economy
Published on 24 April 2026
Chinese-made oral pills could undercut injection costs fast
India’s obesity treatment market is expected to change quickly by year-end as oral GLP1 weight-loss pills become widely available, including new options from China. These tablet therapies promise a cheaper, easier alternative to injectable GLP1 drugs, which could boost patient adoption as convenience and affordability rise. Market analysts expect demand to accelerate as more people can access treatment.
- Oral GLP1 weight-loss pills are set to arrive in India soon
- Chinese manufacturers may expand cheaper options beyond injections
- Convenience and lower cost could drive faster patient adoption
- Year-end timing points to a rapid market shift
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times